BusinessGeneral NewsIndustryInternationalSci-Tech

Genomic Biomarkers Market 2019 To Expand At A CAGR Of 17.65% By Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Inc., MedGenome, Almac Group, Transgenomic Ltd, Sema4 & Others

Global genomic biomarkers market is set to witness a healthy CAGR of 17.65% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing cases of colorectal cancer and rising awareness about benefit of biomarker to treat fatal diseases are the major factor for the growth of this market.

The genomic biomarkers report makes you knowledgeable about the medical device industry and competitive landscape which supports you with enhanced decision making, better manage marketing of goods and decide market goals for better profitability. All the statistical data and information involved in this report is characterized properly by using several charts, graphs or tables. The report provides strategically analyzed market research analysis and observant business insights into the most relevant markets of our clients. This genomic biomarkers market research report helps clients recognize new opportunities and most important customers for their business growth and increased revenue.

Avail a sample copy before purchase: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-genomic-biomarkers-market

Key Market Competitors:

Few of the major competitors currently working in the global genomic biomarkers market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Myriad Genetics, Inc, Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Inc., MedGenome, Almac Group, Transgenomic Ltd, Sema4., GENOME LIFE SCIENCES, Creative Diagnostics, Cancer Genetics Inc., FOUNDATION MEDICINE, INC. CENTOGENE AG,,  Quanterix., and others

Key Developments in the Market:

In September 2018, Cancer Genetics, Inc. and NovellusDx, Ltd announced that they have signed an agreement according to which they are going to merge so that they can combine their data set and test portfolio associated to tumor biology. The main aim of the acquisition is to expand their therapeutic development and provide better treatment to the patient and biopharma companies

In February 2015, Roche announced that they have acquired Signature Diagnostics AG so that they can advance their translational research for their generating sequencing diagnostics. The main aim of the acquisition is to develop their NGS assays using cfDNA so that they can create non- invasive treatment for cancer patients

Market Drivers

Increasing demand for minimally invasive procedure will drive the market

Technological advancement and development in clinical laboratory tests will propel market

Increasing cases gastric and ovarian cancer will also act as a driver for this market

Rising demand for genomic biomarker based medicine will also contribute as a factor for the growth of this market

Market Restraints

Difficulty related with the process of genomics biomarker will also restrain the market

Strict government regulation will also restrain the growth of this market

Inquiry For Customize Report With Discount at :https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-genomic-biomarkers-market

Segmentation: Global Genomic Biomarkers Market

By Application

Oncology

Cardiovascular diseases

Neurological diseases

Others

By End- User

Diagnostic and research laboratories

Hospitals

Others

By Geography

North America

Europe

Asia-Pacific

South America

Middle East and Africa

Competitive Analysis:

Global genomic biomarkers market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of genomic biomarkers market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Get detailed toc @ https://databridgemarketresearch.com/toc/?dbmr=global-genomic-biomarkers-market

Reasons to Purchase this Report

Current and future of global genomic biomarkers market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Available Customizations:

All segmentation provided above in this report is represented at country level

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]

 

 

 

Close